ストックスクリーナーアプリを入手
5.95
0.00%
0.00
アフターアワーズ：
5.97
0.02
+0.34%
Orchestra Biomed Holdings Inc (OBIO) 最新ニュース
Orchestra BioMed Holdings, Inc. (OBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength? - Yahoo Finance
Orchestra BioMed Gets $6.1 Million From Vivasure Sale - mychesco.com
Liquidity Mapping Around (OBIO) Price Events - Stock Traders Daily
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026 - GlobeNewswire
Exploring These 3 Undervalued Small Caps With Insider Buying Across Regions - simplywall.st
Orchestra BioMed Highlights Pivotal Cardiovascular Program Progress - TipRanks
OBIO Maintained by B. Riley Securities -- Price Target Raised to $11.00 - GuruFocus
Orchestra BioMed Holdings Is Maintained at Buy by B. Riley Securities - Moomoo
Orchestra BioMed receives $6.1m milestone from Vivasure deal - Investing.com
Orchestra BioMed receives $6.1m milestone from Vivasure deal By Investing.com - Investing.com UK
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics - GlobeNewswire
B. Riley Adjusts Orchestra BioMed Price Target to $11 From $10, Maintains Buy Rating - marketscreener.com
Orchestra BioMed Obtains $6.1 Million Milestone Payment From Haemonetics' Acquisition of Vivasure - Yahoo Finance
Orchestra BioMed (OBIO) withholds CEO shares for taxes - Stock Titan
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday - Benzinga
BTIG upgrades Orchestra BioMed stock rating on trial progress By Investing.com - Investing.com South Africa
Orchestra Biomed Holdings Inc : Btig Raises t - Moomoo
Orchestra BioMed Shares Rise After BTIG Upgrade - marketscreener.com
Orchestra BioMed at Wells Fargo: partnership model in focus By Investing.com - Investing.com Canada
These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them? - Yahoo Finance
Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results - Benzinga
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday - Benzinga
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
BTIG Upgrades Orchestra BioMed to Buy From Neutral, Price Target is $10 - marketscreener.com
BTIG upgrades Orchestra BioMed stock rating on trial progress - investing.com
Orchestra BioMed CEO David Hochman buys $47,900 in common stock By Investing.com - Investing.com Australia
Orchestra BioMed presents investor slide deck detailing AVIM and Virtue SAB programs, strategic partners and 2027 catalysts - TradingView
Orchestra BioMed CEO David Hochman buys $47,900 in common stock - Investing.com
Orchestra BioMed (OBIO) CEO buys more of his own stock - Stock Titan
Orchestra BioMed Grants 133,000 Options to New Hires - MyChesCo
Orchestra BioMed (OBIO) president sells 15,000 shares under trading plan - Stock Titan
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Insider plans to sell 15,000 Orchestra BioMed (OBIO) shares - Stock Titan
Orchestra BioMed (OBIO) CFO logs 3,076-share tax withholding - Stock Titan
Orchestra BioMed (NASDAQ: OBIO) exec cites tax share withholding and son's 2,000-share buy - Stock Titan
Orchestra BioMed (OBIO) officer sees shares withheld for RSU taxes - Stock Titan
Avoiding Lag: Real-Time Signals in (OBIO) Movement - Stock Traders Daily
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire
Insiders Buying Orchestra BioMed Holdings Might Wish They Invested More, Stock Gains 29% - Moomoo
Orchestra (OBIO) Q2 2026 Results: Profit Per Share Clears Its Benchmark for the Current Session; Investor Response: Shares Finish 19.92% Higher in Latest TradingInvestor Earnings Call - vinanet.vn
Orchestra (OBIO) Reported Results Review: EPS Prints Above Forecast for the Current Session; Price Action: Shares Close 19.92% Higher at the CloseProfit Recovery Report - vinanet.vn
Orchestra BioMed Loss Widens as Pivotal Trials Advance - MyChesCo
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):